Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) was $8.02 for the day, up 1.13% from the previous closing price of $7.93. In other words, the price has increased by $1.13 from its previous closing price. On the day, 1.85 million shares were traded. BCRX stock price reached its highest trading level at $8.1 during the session, while it also had its lowest trading level at $7.854.
Ratios:
Our analysis of BCRX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.73 and its Current Ratio is at 2.78.
On September 18, 2023, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $9 to $10.
Jefferies Upgraded its Hold to Buy on August 04, 2023, while the target price for the stock was maintained at $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 13 ’24 when Hutson Nancy J sold 7,000 shares for $7.54 per share. The transaction valued at 52,780 led to the insider holds 86,638 shares of the business.
Hutson Nancy J bought 7,000 shares of BCRX for $52,584 on Dec 13 ’24. On Jun 24 ’24, another insider, McKee Amy E, who serves as the Director of the company, sold 8,600 shares for $6.32 each. As a result, the insider received 54,352 and left with 27,831 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCRX now has a Market Capitalization of 1661206656 and an Enterprise Value of 2173328128. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.03. Its current Enterprise Value per Revenue stands at 5.268 whereas that against EBITDA is -68.042.
Stock Price History:
The Beta on a monthly basis for BCRX is 1.75, which has changed by 0.5189394 over the last 52 weeks, in comparison to a change of 0.23095727 over the same period for the S&P500. Over the past 52 weeks, BCRX has reached a high of $8.88, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is 5.88%, while the 200-Day Moving Average is calculated to be 13.31%.
Shares Statistics:
BCRX traded an average of 2.26M shares per day over the past three months and 2556890 shares per day over the past ten days. A total of 207.12M shares are outstanding, with a floating share count of 195.42M. Insiders hold about 5.66% of the company’s shares, while institutions hold 82.09% stake in the company. Shares short for BCRX as of 1736899200 were 17013131 with a Short Ratio of 7.54, compared to 1734048000 on 17286947. Therefore, it implies a Short% of Shares Outstanding of 17013131 and a Short% of Float of 8.28.
